Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 26 | 2023 | 66 | 9.000 |
Why?
|
| Thalamus | 7 | 2023 | 23 | 4.220 |
Why?
|
| Subthalamic Nucleus | 12 | 2023 | 32 | 3.890 |
Why?
|
| Parkinson Disease | 16 | 2023 | 842 | 2.830 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 5 | 2019 | 10 | 2.140 |
Why?
|
| Microelectrodes | 8 | 2020 | 26 | 1.890 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 67 | 1.800 |
Why?
|
| Neurosurgical Procedures | 5 | 2022 | 130 | 1.430 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2021 | 12 | 1.390 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2020 | 9 | 1.390 |
Why?
|
| Prosthesis Implantation | 3 | 2017 | 31 | 1.360 |
Why?
|
| Neuronavigation | 3 | 2019 | 6 | 1.360 |
Why?
|
| Humans | 53 | 2023 | 26260 | 1.300 |
Why?
|
| Implantable Neurostimulators | 2 | 2020 | 8 | 1.300 |
Why?
|
| Epilepsy | 2 | 2020 | 66 | 1.270 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2023 | 1157 | 1.180 |
Why?
|
| White Matter | 2 | 2021 | 142 | 1.170 |
Why?
|
| Brain | 4 | 2021 | 1643 | 1.090 |
Why?
|
| Essential Tremor | 3 | 2023 | 8 | 1.070 |
Why?
|
| Female | 30 | 2022 | 14516 | 1.000 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2019 | 723 | 0.990 |
Why?
|
| Stereotaxic Techniques | 5 | 2020 | 19 | 0.980 |
Why?
|
| Male | 28 | 2022 | 14124 | 0.910 |
Why?
|
| Middle Aged | 22 | 2022 | 8600 | 0.850 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2021 | 26 | 0.820 |
Why?
|
| Hematoma | 1 | 2022 | 16 | 0.800 |
Why?
|
| Aged | 19 | 2022 | 8764 | 0.790 |
Why?
|
| Tremor | 1 | 2023 | 118 | 0.770 |
Why?
|
| Adult | 17 | 2021 | 7447 | 0.760 |
Why?
|
| Hand | 2 | 2019 | 38 | 0.750 |
Why?
|
| Neurosurgery | 2 | 2020 | 34 | 0.750 |
Why?
|
| Electrodes, Implanted | 5 | 2019 | 26 | 0.750 |
Why?
|
| Monitoring, Intraoperative | 3 | 2022 | 37 | 0.750 |
Why?
|
| Third Ventricle | 1 | 2021 | 2 | 0.740 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 108 | 0.740 |
Why?
|
| Nerve Net | 1 | 2021 | 47 | 0.720 |
Why?
|
| Temporal Lobe | 1 | 2021 | 85 | 0.710 |
Why?
|
| Postoperative Complications | 3 | 2016 | 868 | 0.710 |
Why?
|
| Gray Matter | 1 | 2021 | 55 | 0.710 |
Why?
|
| Stents | 3 | 2005 | 76 | 0.710 |
Why?
|
| Intraoperative Care | 2 | 2017 | 39 | 0.700 |
Why?
|
| Cochlear Implants | 1 | 2020 | 24 | 0.700 |
Why?
|
| Treatment Outcome | 13 | 2023 | 3390 | 0.690 |
Why?
|
| Functional Laterality | 3 | 2018 | 65 | 0.690 |
Why?
|
| Epilepsies, Partial | 1 | 2019 | 15 | 0.670 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 160 | 0.660 |
Why?
|
| Brain Edema | 2 | 2016 | 20 | 0.660 |
Why?
|
| Movement | 2 | 2023 | 110 | 0.660 |
Why?
|
| Beta Rhythm | 1 | 2019 | 4 | 0.640 |
Why?
|
| Movement Disorders | 1 | 2019 | 90 | 0.620 |
Why?
|
| Vancomycin | 1 | 2018 | 52 | 0.610 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 36 | 0.610 |
Why?
|
| Nerve Fibers | 1 | 2018 | 13 | 0.600 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 82 | 0.590 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2017 | 3 | 0.570 |
Why?
|
| Cognition | 4 | 2023 | 1291 | 0.560 |
Why?
|
| Epithalamus | 1 | 2016 | 3 | 0.550 |
Why?
|
| Afferent Pathways | 1 | 2016 | 5 | 0.550 |
Why?
|
| Craniotomy | 1 | 2016 | 21 | 0.550 |
Why?
|
| Neurilemmoma | 1 | 2016 | 15 | 0.550 |
Why?
|
| Lymphangioma | 1 | 2016 | 4 | 0.530 |
Why?
|
| Critical Care Nursing | 1 | 2016 | 12 | 0.520 |
Why?
|
| Neurosciences | 1 | 2016 | 10 | 0.520 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 339 | 0.520 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 24 | 0.510 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2016 | 34 | 0.510 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 53 | 0.500 |
Why?
|
| Decompressive Craniectomy | 1 | 2015 | 3 | 0.500 |
Why?
|
| Intracranial Aneurysm | 2 | 2005 | 41 | 0.480 |
Why?
|
| Embolization, Therapeutic | 2 | 2005 | 56 | 0.470 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 117 | 0.460 |
Why?
|
| Feasibility Studies | 3 | 2022 | 210 | 0.430 |
Why?
|
| Retrospective Studies | 6 | 2021 | 3366 | 0.420 |
Why?
|
| Glioma | 3 | 2021 | 19 | 0.420 |
Why?
|
| Adolescent | 4 | 2021 | 2079 | 0.420 |
Why?
|
| Brain Neoplasms | 3 | 2021 | 76 | 0.410 |
Why?
|
| Workflow | 2 | 2023 | 12 | 0.390 |
Why?
|
| Stroke | 1 | 2015 | 260 | 0.390 |
Why?
|
| Brain Mapping | 3 | 2021 | 171 | 0.370 |
Why?
|
| Young Adult | 3 | 2021 | 1886 | 0.340 |
Why?
|
| Sex Factors | 2 | 2021 | 450 | 0.330 |
Why?
|
| Hypothalamus, Posterior | 1 | 2009 | 1 | 0.330 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 4675 | 0.310 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 1 | 2008 | 3 | 0.310 |
Why?
|
| Hemostasis, Surgical | 1 | 2008 | 12 | 0.310 |
Why?
|
| Prevalence | 2 | 2021 | 437 | 0.310 |
Why?
|
| Collagen | 1 | 2008 | 81 | 0.300 |
Why?
|
| Neuroimaging | 2 | 2019 | 134 | 0.300 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2007 | 3 | 0.300 |
Why?
|
| Decompression, Surgical | 2 | 2005 | 129 | 0.280 |
Why?
|
| Cranial Sinuses | 1 | 2005 | 3 | 0.260 |
Why?
|
| Parietal Lobe | 1 | 2005 | 18 | 0.260 |
Why?
|
| Wounds, Penetrating | 1 | 2005 | 8 | 0.250 |
Why?
|
| Brown-Sequard Syndrome | 1 | 2005 | 5 | 0.250 |
Why?
|
| Middle Cerebral Artery | 1 | 2005 | 7 | 0.250 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2005 | 10 | 0.250 |
Why?
|
| Pituitary Apoplexy | 1 | 2005 | 2 | 0.250 |
Why?
|
| Glucosylceramidase | 2 | 2022 | 19 | 0.250 |
Why?
|
| Epidermal Cyst | 1 | 2005 | 6 | 0.250 |
Why?
|
| Sphenoid Sinus | 1 | 2005 | 15 | 0.250 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2005 | 14 | 0.250 |
Why?
|
| Spinal Stenosis | 1 | 2005 | 37 | 0.250 |
Why?
|
| Carotid Artery, Internal | 1 | 2005 | 8 | 0.250 |
Why?
|
| Laminectomy | 1 | 2005 | 43 | 0.250 |
Why?
|
| Aneurysm | 1 | 2005 | 10 | 0.240 |
Why?
|
| Cervical Vertebrae | 2 | 2005 | 301 | 0.240 |
Why?
|
| Electric Stimulation | 2 | 2019 | 50 | 0.240 |
Why?
|
| Hippocampus | 2 | 2021 | 262 | 0.240 |
Why?
|
| Obesity | 1 | 2007 | 279 | 0.240 |
Why?
|
| Evoked Potentials, Motor | 2 | 2022 | 11 | 0.240 |
Why?
|
| Paresthesia | 1 | 2023 | 3 | 0.220 |
Why?
|
| Dysarthria | 1 | 2023 | 3 | 0.220 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 41 | 0.210 |
Why?
|
| Heparin | 1 | 2002 | 18 | 0.210 |
Why?
|
| Brain Chemistry | 1 | 2002 | 42 | 0.210 |
Why?
|
| Eye Movements | 1 | 2022 | 13 | 0.200 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2022 | 8 | 0.200 |
Why?
|
| Suction | 1 | 2022 | 38 | 0.200 |
Why?
|
| Plaque, Amyloid | 1 | 2002 | 142 | 0.200 |
Why?
|
| Heterozygote | 1 | 2022 | 93 | 0.190 |
Why?
|
| Anticonvulsants | 2 | 2019 | 56 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 1 | 2002 | 319 | 0.180 |
Why?
|
| Globus Pallidus | 1 | 2020 | 12 | 0.180 |
Why?
|
| Connectome | 1 | 2020 | 12 | 0.170 |
Why?
|
| Age Factors | 2 | 2018 | 751 | 0.170 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 1738 | 0.170 |
Why?
|
| Neuropsychological Tests | 2 | 2022 | 1223 | 0.160 |
Why?
|
| Infant | 1 | 2021 | 520 | 0.160 |
Why?
|
| Child, Preschool | 1 | 2021 | 593 | 0.160 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 32 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2018 | 32 | 0.160 |
Why?
|
| Headache | 2 | 2011 | 33 | 0.150 |
Why?
|
| Seizures | 1 | 2018 | 65 | 0.150 |
Why?
|
| Habenula | 1 | 2016 | 3 | 0.140 |
Why?
|
| Case-Control Studies | 2 | 2017 | 566 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 187 | 0.140 |
Why?
|
| Dystonic Disorders | 1 | 2016 | 5 | 0.140 |
Why?
|
| Operative Time | 1 | 2017 | 85 | 0.140 |
Why?
|
| Child | 1 | 2021 | 1235 | 0.140 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2017 | 54 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2017 | 122 | 0.130 |
Why?
|
| Databases, Bibliographic | 1 | 2015 | 8 | 0.130 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 9 | 0.130 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 10 | 0.130 |
Why?
|
| Hematoma, Subdural | 1 | 2015 | 8 | 0.130 |
Why?
|
| Illinois | 1 | 2016 | 231 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 186 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 677 | 0.120 |
Why?
|
| Acute Disease | 2 | 2005 | 192 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2018 | 1838 | 0.120 |
Why?
|
| Electromyography | 2 | 2022 | 61 | 0.110 |
Why?
|
| Radiography | 2 | 2005 | 616 | 0.110 |
Why?
|
| Aging | 1 | 2002 | 1538 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2007 | 570 | 0.100 |
Why?
|
| Neurons | 2 | 2020 | 312 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 411 | 0.090 |
Why?
|
| Mutation | 2 | 2022 | 315 | 0.090 |
Why?
|
| Cluster Headache | 1 | 2009 | 1 | 0.080 |
Why?
|
| Red Nucleus | 1 | 2009 | 1 | 0.080 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 2009 | 1 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2009 | 15 | 0.080 |
Why?
|
| Electrophysiology | 1 | 2009 | 95 | 0.080 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2008 | 3 | 0.080 |
Why?
|
| Drinking | 1 | 2007 | 5 | 0.070 |
Why?
|
| Animals | 2 | 2007 | 3391 | 0.070 |
Why?
|
| Eating | 1 | 2007 | 48 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 318 | 0.070 |
Why?
|
| Rats | 1 | 2007 | 596 | 0.070 |
Why?
|
| Construction Materials | 1 | 2005 | 2 | 0.060 |
Why?
|
| Fascia | 1 | 2005 | 8 | 0.060 |
Why?
|
| Cervical Plexus | 1 | 2005 | 3 | 0.060 |
Why?
|
| Spinal Nerve Roots | 1 | 2005 | 15 | 0.060 |
Why?
|
| Paralysis | 1 | 2005 | 15 | 0.060 |
Why?
|
| Diplopia | 1 | 2005 | 3 | 0.060 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 101 | 0.060 |
Why?
|
| Equipment Design | 1 | 2005 | 144 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 281 | 0.060 |
Why?
|
| Cadaver | 1 | 2005 | 370 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2005 | 1668 | 0.050 |
Why?
|
| Cholinesterases | 1 | 2002 | 1 | 0.050 |
Why?
|
| Chymotrypsin | 1 | 2002 | 3 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2002 | 130 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2002 | 65 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 337 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2002 | 251 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 24 | 0.050 |
Why?
|
| Dyskinesias | 1 | 2020 | 22 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2022 | 333 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 400 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 46 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 621 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 936 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1343 | 0.030 |
Why?
|
| Valproic Acid | 1 | 2011 | 12 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 67 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 92 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 78 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 290 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 288 | 0.020 |
Why?
|
| Medical Records | 1 | 2008 | 31 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 853 | 0.020 |
Why?
|